Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China

March 29, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search